Stratified medicine for mental disorders

Gunter Schumann, Elisabeth B. Binder, Arne Holte, E. Ronald de Kloet, Ketil J. Oedegaard, Trevor W. Robbins, Tom R. Walker-Tilley, I. Bitter, Verity J. Brown, Jan Buitelaar, Roberto Ciccocioppo, Roshan Cools, Carles Escera, Wolfgang Fleischhacker, Herta Flor, Chris D. Frith, Andreas Heinz, Erik Johnsen, Clemens Kirschbaum, Torkel KlingbergKlaus Peter Lesch, Shon Lewis, Wolfgang Maier, Karl Mann, Jean Luc Martinot, Andreas Meyer-Lindenberg, Christian P. Müller, Walter E. Müller, David J. Nutt, Antonio Persico, Giulio Perugi, Mathias Pessiglione, Ulrich W. Preuss, Jonathan P. Roiser, Paolo M. Rossini, Janusz K. Rybakowski, Carmen Sandi, Klaas E. Stephan, Juan Undurraga, Eduard Vieta, Nic van der Wee, Til Wykes, Josep Maria Haro, Hans Ulrich Wittchen

Research output: Contribution to journalArticle

102 Citations (Scopus)

Abstract

There is recognition that biomedical research into the causes of mental disorders and their treatment needs to adopt new approaches to research. Novel biomedical techniques have advanced our understanding of how the brain develops and is shaped by behaviour and environment. This has led to the advent of stratified medicine, which translates advances in basic research by targeting aetiological mechanisms underlying mental disorder. The resulting increase in diagnostic precision and targeted treatments may provide a window of opportunity to address the large public health burden, and individual suffering associated with mental disorders.While mental health and mental disorders have significant representation in the "health, demographic change and wellbeing" challenge identified in Horizon 2020, the framework programme for research and innovation of the European Commission (2014-2020), and in national funding agencies, clear advice on a potential strategy for mental health research investment is needed. The development of such a strategy is supported by the EC-funded "Roadmap for Mental Health Research" (ROAMER) which will provide recommendations for a European mental health research strategy integrating the areas of biomedicine, psychology, public health well being, research integration and structuring, and stakeholder participation. Leading experts on biomedical research on mental disorders have provided an assessment of the state of the art in core psychopathological domains, including arousal and stress regulation, affect, cognition social processes, comorbidity and pharmacotherapy. They have identified major advances and promising methods and pointed out gaps to be addressed in order to achieve the promise of a stratified medicine for mental disorders.

Original languageEnglish
Pages (from-to)5-50
Number of pages46
JournalEuropean Neuropsychopharmacology
Volume24
Issue number1
DOIs
Publication statusPublished - Jan 2014

Fingerprint

Mental Disorders
Research
Mental Health
Biomedical Research
Public Health
Arousal
Psychological Stress
Cognition
Comorbidity
Medicine
Demography
Psychology
Drug Therapy
Health
Brain
Therapeutics

Keywords

  • Mental disorder
  • Neural processes
  • Psychopathology
  • Roadmap
  • Stratified medicine
  • Treatment

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Pharmacology (medical)
  • Biological Psychiatry
  • Neurology
  • Pharmacology

Cite this

Schumann, G., Binder, E. B., Holte, A., de Kloet, E. R., Oedegaard, K. J., Robbins, T. W., ... Wittchen, H. U. (2014). Stratified medicine for mental disorders. European Neuropsychopharmacology, 24(1), 5-50. https://doi.org/10.1016/j.euroneuro.2013.09.010

Stratified medicine for mental disorders. / Schumann, Gunter; Binder, Elisabeth B.; Holte, Arne; de Kloet, E. Ronald; Oedegaard, Ketil J.; Robbins, Trevor W.; Walker-Tilley, Tom R.; Bitter, I.; Brown, Verity J.; Buitelaar, Jan; Ciccocioppo, Roberto; Cools, Roshan; Escera, Carles; Fleischhacker, Wolfgang; Flor, Herta; Frith, Chris D.; Heinz, Andreas; Johnsen, Erik; Kirschbaum, Clemens; Klingberg, Torkel; Lesch, Klaus Peter; Lewis, Shon; Maier, Wolfgang; Mann, Karl; Martinot, Jean Luc; Meyer-Lindenberg, Andreas; Müller, Christian P.; Müller, Walter E.; Nutt, David J.; Persico, Antonio; Perugi, Giulio; Pessiglione, Mathias; Preuss, Ulrich W.; Roiser, Jonathan P.; Rossini, Paolo M.; Rybakowski, Janusz K.; Sandi, Carmen; Stephan, Klaas E.; Undurraga, Juan; Vieta, Eduard; van der Wee, Nic; Wykes, Til; Haro, Josep Maria; Wittchen, Hans Ulrich.

In: European Neuropsychopharmacology, Vol. 24, No. 1, 01.2014, p. 5-50.

Research output: Contribution to journalArticle

Schumann, G, Binder, EB, Holte, A, de Kloet, ER, Oedegaard, KJ, Robbins, TW, Walker-Tilley, TR, Bitter, I, Brown, VJ, Buitelaar, J, Ciccocioppo, R, Cools, R, Escera, C, Fleischhacker, W, Flor, H, Frith, CD, Heinz, A, Johnsen, E, Kirschbaum, C, Klingberg, T, Lesch, KP, Lewis, S, Maier, W, Mann, K, Martinot, JL, Meyer-Lindenberg, A, Müller, CP, Müller, WE, Nutt, DJ, Persico, A, Perugi, G, Pessiglione, M, Preuss, UW, Roiser, JP, Rossini, PM, Rybakowski, JK, Sandi, C, Stephan, KE, Undurraga, J, Vieta, E, van der Wee, N, Wykes, T, Haro, JM & Wittchen, HU 2014, 'Stratified medicine for mental disorders', European Neuropsychopharmacology, vol. 24, no. 1, pp. 5-50. https://doi.org/10.1016/j.euroneuro.2013.09.010
Schumann G, Binder EB, Holte A, de Kloet ER, Oedegaard KJ, Robbins TW et al. Stratified medicine for mental disorders. European Neuropsychopharmacology. 2014 Jan;24(1):5-50. https://doi.org/10.1016/j.euroneuro.2013.09.010
Schumann, Gunter ; Binder, Elisabeth B. ; Holte, Arne ; de Kloet, E. Ronald ; Oedegaard, Ketil J. ; Robbins, Trevor W. ; Walker-Tilley, Tom R. ; Bitter, I. ; Brown, Verity J. ; Buitelaar, Jan ; Ciccocioppo, Roberto ; Cools, Roshan ; Escera, Carles ; Fleischhacker, Wolfgang ; Flor, Herta ; Frith, Chris D. ; Heinz, Andreas ; Johnsen, Erik ; Kirschbaum, Clemens ; Klingberg, Torkel ; Lesch, Klaus Peter ; Lewis, Shon ; Maier, Wolfgang ; Mann, Karl ; Martinot, Jean Luc ; Meyer-Lindenberg, Andreas ; Müller, Christian P. ; Müller, Walter E. ; Nutt, David J. ; Persico, Antonio ; Perugi, Giulio ; Pessiglione, Mathias ; Preuss, Ulrich W. ; Roiser, Jonathan P. ; Rossini, Paolo M. ; Rybakowski, Janusz K. ; Sandi, Carmen ; Stephan, Klaas E. ; Undurraga, Juan ; Vieta, Eduard ; van der Wee, Nic ; Wykes, Til ; Haro, Josep Maria ; Wittchen, Hans Ulrich. / Stratified medicine for mental disorders. In: European Neuropsychopharmacology. 2014 ; Vol. 24, No. 1. pp. 5-50.
@article{eb1e0d881a20403aa659cd8c56ec774a,
title = "Stratified medicine for mental disorders",
abstract = "There is recognition that biomedical research into the causes of mental disorders and their treatment needs to adopt new approaches to research. Novel biomedical techniques have advanced our understanding of how the brain develops and is shaped by behaviour and environment. This has led to the advent of stratified medicine, which translates advances in basic research by targeting aetiological mechanisms underlying mental disorder. The resulting increase in diagnostic precision and targeted treatments may provide a window of opportunity to address the large public health burden, and individual suffering associated with mental disorders.While mental health and mental disorders have significant representation in the {"}health, demographic change and wellbeing{"} challenge identified in Horizon 2020, the framework programme for research and innovation of the European Commission (2014-2020), and in national funding agencies, clear advice on a potential strategy for mental health research investment is needed. The development of such a strategy is supported by the EC-funded {"}Roadmap for Mental Health Research{"} (ROAMER) which will provide recommendations for a European mental health research strategy integrating the areas of biomedicine, psychology, public health well being, research integration and structuring, and stakeholder participation. Leading experts on biomedical research on mental disorders have provided an assessment of the state of the art in core psychopathological domains, including arousal and stress regulation, affect, cognition social processes, comorbidity and pharmacotherapy. They have identified major advances and promising methods and pointed out gaps to be addressed in order to achieve the promise of a stratified medicine for mental disorders.",
keywords = "Mental disorder, Neural processes, Psychopathology, Roadmap, Stratified medicine, Treatment",
author = "Gunter Schumann and Binder, {Elisabeth B.} and Arne Holte and {de Kloet}, {E. Ronald} and Oedegaard, {Ketil J.} and Robbins, {Trevor W.} and Walker-Tilley, {Tom R.} and I. Bitter and Brown, {Verity J.} and Jan Buitelaar and Roberto Ciccocioppo and Roshan Cools and Carles Escera and Wolfgang Fleischhacker and Herta Flor and Frith, {Chris D.} and Andreas Heinz and Erik Johnsen and Clemens Kirschbaum and Torkel Klingberg and Lesch, {Klaus Peter} and Shon Lewis and Wolfgang Maier and Karl Mann and Martinot, {Jean Luc} and Andreas Meyer-Lindenberg and M{\"u}ller, {Christian P.} and M{\"u}ller, {Walter E.} and Nutt, {David J.} and Antonio Persico and Giulio Perugi and Mathias Pessiglione and Preuss, {Ulrich W.} and Roiser, {Jonathan P.} and Rossini, {Paolo M.} and Rybakowski, {Janusz K.} and Carmen Sandi and Stephan, {Klaas E.} and Juan Undurraga and Eduard Vieta and {van der Wee}, Nic and Til Wykes and Haro, {Josep Maria} and Wittchen, {Hans Ulrich}",
year = "2014",
month = "1",
doi = "10.1016/j.euroneuro.2013.09.010",
language = "English",
volume = "24",
pages = "5--50",
journal = "European Neuropsychopharmacology",
issn = "0924-977X",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Stratified medicine for mental disorders

AU - Schumann, Gunter

AU - Binder, Elisabeth B.

AU - Holte, Arne

AU - de Kloet, E. Ronald

AU - Oedegaard, Ketil J.

AU - Robbins, Trevor W.

AU - Walker-Tilley, Tom R.

AU - Bitter, I.

AU - Brown, Verity J.

AU - Buitelaar, Jan

AU - Ciccocioppo, Roberto

AU - Cools, Roshan

AU - Escera, Carles

AU - Fleischhacker, Wolfgang

AU - Flor, Herta

AU - Frith, Chris D.

AU - Heinz, Andreas

AU - Johnsen, Erik

AU - Kirschbaum, Clemens

AU - Klingberg, Torkel

AU - Lesch, Klaus Peter

AU - Lewis, Shon

AU - Maier, Wolfgang

AU - Mann, Karl

AU - Martinot, Jean Luc

AU - Meyer-Lindenberg, Andreas

AU - Müller, Christian P.

AU - Müller, Walter E.

AU - Nutt, David J.

AU - Persico, Antonio

AU - Perugi, Giulio

AU - Pessiglione, Mathias

AU - Preuss, Ulrich W.

AU - Roiser, Jonathan P.

AU - Rossini, Paolo M.

AU - Rybakowski, Janusz K.

AU - Sandi, Carmen

AU - Stephan, Klaas E.

AU - Undurraga, Juan

AU - Vieta, Eduard

AU - van der Wee, Nic

AU - Wykes, Til

AU - Haro, Josep Maria

AU - Wittchen, Hans Ulrich

PY - 2014/1

Y1 - 2014/1

N2 - There is recognition that biomedical research into the causes of mental disorders and their treatment needs to adopt new approaches to research. Novel biomedical techniques have advanced our understanding of how the brain develops and is shaped by behaviour and environment. This has led to the advent of stratified medicine, which translates advances in basic research by targeting aetiological mechanisms underlying mental disorder. The resulting increase in diagnostic precision and targeted treatments may provide a window of opportunity to address the large public health burden, and individual suffering associated with mental disorders.While mental health and mental disorders have significant representation in the "health, demographic change and wellbeing" challenge identified in Horizon 2020, the framework programme for research and innovation of the European Commission (2014-2020), and in national funding agencies, clear advice on a potential strategy for mental health research investment is needed. The development of such a strategy is supported by the EC-funded "Roadmap for Mental Health Research" (ROAMER) which will provide recommendations for a European mental health research strategy integrating the areas of biomedicine, psychology, public health well being, research integration and structuring, and stakeholder participation. Leading experts on biomedical research on mental disorders have provided an assessment of the state of the art in core psychopathological domains, including arousal and stress regulation, affect, cognition social processes, comorbidity and pharmacotherapy. They have identified major advances and promising methods and pointed out gaps to be addressed in order to achieve the promise of a stratified medicine for mental disorders.

AB - There is recognition that biomedical research into the causes of mental disorders and their treatment needs to adopt new approaches to research. Novel biomedical techniques have advanced our understanding of how the brain develops and is shaped by behaviour and environment. This has led to the advent of stratified medicine, which translates advances in basic research by targeting aetiological mechanisms underlying mental disorder. The resulting increase in diagnostic precision and targeted treatments may provide a window of opportunity to address the large public health burden, and individual suffering associated with mental disorders.While mental health and mental disorders have significant representation in the "health, demographic change and wellbeing" challenge identified in Horizon 2020, the framework programme for research and innovation of the European Commission (2014-2020), and in national funding agencies, clear advice on a potential strategy for mental health research investment is needed. The development of such a strategy is supported by the EC-funded "Roadmap for Mental Health Research" (ROAMER) which will provide recommendations for a European mental health research strategy integrating the areas of biomedicine, psychology, public health well being, research integration and structuring, and stakeholder participation. Leading experts on biomedical research on mental disorders have provided an assessment of the state of the art in core psychopathological domains, including arousal and stress regulation, affect, cognition social processes, comorbidity and pharmacotherapy. They have identified major advances and promising methods and pointed out gaps to be addressed in order to achieve the promise of a stratified medicine for mental disorders.

KW - Mental disorder

KW - Neural processes

KW - Psychopathology

KW - Roadmap

KW - Stratified medicine

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84892623734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892623734&partnerID=8YFLogxK

U2 - 10.1016/j.euroneuro.2013.09.010

DO - 10.1016/j.euroneuro.2013.09.010

M3 - Article

C2 - 24176673

AN - SCOPUS:84892623734

VL - 24

SP - 5

EP - 50

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

SN - 0924-977X

IS - 1

ER -